Indeed, preclinical studies have shown that spliceosome-mutant cancer cells are selectively sensitive to ATR inhibitors; the drugs cause excessive DNA damage and cell death in those cells, a phenotype that can be rescued by overexpression of RNase H1, proving R-loops were the cause of the vulnerability [82]. Here, ATR is linked to cancer.